Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Diabetes Care|December 10, 1999
Renal disease as a determinant of increased lipoprotein(a) concentrations in diabetic patientsM Boemi, C Sirolla, P Fumelli, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|January 1, 1993
Arterial hypertension and cardiovascular damage in the elderly: focus on arterial stiffness and left ventricular hypertrophyE Paciaroni, R Antonicelli, C Gambini, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|November 14, 1997
Reproducibility of normal facial motor nerve conduction studies and their relevance in the electrophysiological assessment of peripheral facial paralysisP Di Bella, F Logullo, G Lagalla, et al.
Diabetologia|June 1, 1995
Lipoprotein (a) and vascular disease in diabetic patientsR W James, M Boemi, C Sirolla, et al.
Diabetes Care|April 1, 1995
Apolipoprotein E polymorphism as a risk factor for vascular disease in diabetic patientsM Boemi, C Sirolla, L Amadio, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 20, 2004
Smoking is associated with reduced serum levels of the antioxidant enzyme, paraoxonase, in Type 2 diabetic patientsM Boemi, C Sirolla, R Testa, et al.
International Journal of Clinical & Laboratory Research|November 5, 1998
A significant relationship between plasminogen activator inhibitor type-1 and lipoprotein(a) in non-insulin-dependent diabetes mellitus without complicationsR Testa, A R Bonfigli, C Pieri, et al.
European Journal of Clinical Investigation|March 29, 2003
Apolipoprotein E polymorphisms and mortality in Italian type 2 diabetic patientsM Boemi, C Sirolla, R Testa, et al.
Clinical and Experimental Medicine|February 9, 2002
Relationship between lipoprotein(a) levels, oxidative stress, and blood pressure levels in patients with essential hypertensionR Antonicelli, R Testa, A R Bonfigli, et al.
Pageof 2